Oncology Central

Using circulating tumor cells to guide therapy in breast cancer: could this replace biopsies?

0

Over the last two decades we have seen a number of important advances in the biological underpinnings of breast cancer that have had a significant impact either directly or indirectly on the management and ultimately on the prognostic outcome of this disease. First, we now know that breast cancer is a heterogeneous disease made up of a number of unique subtypes each with its own natural history and associated prognostic outcome [1].

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.

Share:

Insights

Videos

News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.